Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Buy dildos and sex toys.
Popular Articles

Private Insurers Step Into Spotlight On Health Care Reform
"Don"t expect the private insurance industry to go away under any kind of health-care reform initiative. That"s because most key health-reform measures gaining momentum in Washington not only leave private health plans intact but also may give them a greater role," The Chicago Tribune reports. Insurers also "got to ride the coattails" of the America Medical Association"s support for the private insurance system as President Barack Obama "sought the physicians" support" of his public insurance option. Health plans were "happy that the AMA stripped the words "public option" from a resolution."
buy viagra
Local Researcher Shows Botox Clears Up Acne!
The muscle relaxer Botox has now been shown to positively affect the skin as well.
News of the day
Obama Considers Taxing Health Benefits To Pay For Reform
As President Obama looks for a way to pay for health care reform in the United States, key Democrats advocate taxing employer-provided health benefits, The Washington Post reports.
Cardiovascular

Society Welcomes Decision On Ephedrine And Pseudoephedrine

The Royal Pharmaceutical Society welcomed the decision by the Medicines and Healthcare Products Regulatory Agency that medicines containing ephedrine and pseudoephedrine should retain their status as pharmacy (P) medicines. President Steve Churton said: "We are delighted at the MHRA"s decision to keep cold and flu remedies containing ephedrine and pseudoephedrine as pharmacy (P) medicines. "The decision is a ringing endorsement of the vigilance pharmacists have shown in monitoring and controlling the sale of these products. "Pharmacists are experts in medicines and experienced in dealing with medicines liable to misuse. The MHRA"s decision is great news for consumers and provides a clear signal of faith in the pharmacy profession. "I urge pharmacists to continue to remain alert to the supply of these medicines so that they continue to keep their P status". Notes The MHRA have taken this decision taken following the review by the Commission on Human Medicines (CHM) of the measures introduced from July 2007 to control the risk of misuse of OTC medicines containing pseudoephedrine and ephedrine, in the manufacture of the Class A controlled drug methylamphetamine http://www.mhra.gov.uk Royal Pharmaceutical Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009